Aims and objectives

The ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) focuses on the challenges posed by Staphylococcus aureus, one of the most frequent bacterial pathogens in both community and healthcare settings. With staphylococcal infections on the rise, ESGS is committed more than ever to understanding S. aureus complex pathogenesis and interactions with human hosts. Their common mission is focused on: 

  • Coordinating pioneering fundamental and applied research across Europe in this vital area
  • Fostering collaboration among microbiologists, clinicians, and researchers to tackle key clinical questions, thereby turning research breakthroughs into clinical applications
  • Developing comprehensive guidelines to improve the diagnosis, clinical management, and prevention of staphylococcal colonisation and infection
  • Supporting educational initiatives at both Master's and PhD levels, cultivating the next generation of experts in this field
  • Strengthening the network of researchers to enhance the visibility and impact of the staphylococcal research community

Activities and resources

Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis. 

Wirth T, Bergot M, Rasigade J-P, Pichon B, Barbier M, Martins-Simoes P, Jacob L, Pike R, Tissieres P, Picaud J-C, Kearns A, Supply P, Butin M, Laurent F, International Consortium for Staphylococcus capitis neonatal sepsis, ESGS Study Group of ESCMID. Nat Microbiol. 2020;5(5):735–745.

Go to publication


Implications of identifying the recently defined members of the Staphylococcus aureus complex S. argenteus and S. schweitzeri: a position paper of members of the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS). 

Becker K, Schaumburg F, Kearns A, Larsen AR, Lindsay JA, Skov RL, Westh H. Clin Microbiol Infect. 2019;25(9):1064–1070.

Go to publication

ESGS webinar - Staphylococcus aureus: Probiotics and decolonisation; GWAS and AI

Go to webinar


Staphylococcus aureus: Platelets and the SNAP trial

Go to webinar


Staphylococcus aureus: Cell-intrinsic immunity to staphylococcal α-toxin and adjunctive agents

Go to webinar

Executive Committee

  Marc Stegger

Marc Stegger

Chair
Statens Serum Institut. Department of Bacteria, Parasites and Fungi
Copenhagen, Denmark
  Marjolein Hensgens

Marjolein Hensgens

Education Officer
UMC Utrecht
Utrecht, Netherlands
  Steven Tong

Steven Tong

Science Officer
Doherty Institute for Infection and Immunity. Victorian Infectious Diseases Service
Melbourne, Australia
  Barbara C. Kahl

Barbara C. Kahl

Treasurer
Institut für Med. Mikrobiologie Universitätsklinikum Münster
Münster, Germany
  Anna Goodman

Anna Goodman

Secretary
NHS. Infection
London, United Kingdom

Contact

If you have questions or comments for our study group, we warmly invite you to contact us!

Contact form